Entrepreneurs need to put a value on their start-ups in order to raise money, and investors need to put a value on their investments to ensure an adequate return on investment. No negotiating item between entrepreneur and investor creates a wider gulf than this one. The two parties may agree on every other point but will have diametrically opposing views on what the start-up is worth and how much equity the investor should receive in exchange for his capital.
Valuation is challenging for a start-up. Since young businesses take time to become profitable, the trick of valuing start-ups is to focus on the future. If you want your start-up to be a masterpiece, you’ll need to use the right side of your brain as much as your left to determine value.
Is business valuation art or science? Is it possible to place a credible valuation on a Start-up? What is Pre-money valuation? What is Post-money valuation? How much your company worth? Are you really worth anything until you’re profitable? How to value your start-up for a VC? What are the Start-up valuation methods?
2. What is Value?
• Some common barbs about “value”
– “Value lies in the eye of the beholder.”
– “A cynic is someone who knows the price of
everything and the value of nothing.”
• Valuation is a systematic, disciplined approach, not a
science.
• Value = Monetary estimate of the benefit from owning an
asset or the right to exploit an asset
• Useful for
• Raising Capital
• Selling /buying / merging businesses and companies
• Public floatations
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
3. Why Care About Valuation
• Share of Wealth
• Control
Two possible
outcomes
Founder Ownership
Founder Ownership After Sharing
Before Sharing
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
4. What happens when a company
issues shares to raise capital?
Demystifying Valuation ForStartups- Dr. G. Sabarinathan
5. Equity Dilution Illustrated
Position of HiGrow Ltd., prior to raising any external equity
No of shares 1,000
Value of Assets 10,000
Value per share 10
Founder's share 100%
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
6. Impact of Dilution
• Let us say until the issue of the Pre Diln Post Diln
additional 250 shares, all the shares Founder 100% 80%
were held by the promoters.
Investor 0% 20%
• The promoters held 100% of the
equity of the company. Total 100% 100%
• This represents 100% of the control Founder 1,000 1,000
as well as wealth of the company. Investor 0 250
• After the dilution the promoters Total 1,000 1,250
share 20% of the control as well as
the wealth of the firm. Value 10,000 25,000
• Why would the Founder agree to
such a deal?
Founder Ownership Founder Ownership
Demystifying Valuation ForStartups - Dr. G. Sabarinathan Before Sharing After Sharing
7. Equity Dilution
No of Shares • Value of the equity before funding
Pre Fund Post Fund is Rs 10,000
Rs/ lakhs Rs/ lakhs • Funding causes
• Drop in founder’s share of wealth
Founder 1000 1000
• Increase in value of firm’s equity
Investor 0 250 • Increase in founders’ wealth
Total 1000 1250 => “Growing pie” paradigm
% Equity • Dilution is financially wise for founder
Founder 100% 80% • Investor’s view is another story
• Deal will happen only if both see
Investor 0% 20%
financial sense in the deal, though….
Total 100% 100%
Value • Post Money Valuation: Value of firm / equity after
Rs/ lakhs Rs/ lakhs funding
• Pre money Valuation: Value of equity existing at the
Founder 10,000 25,000
time of funding
Investor 0 5,000 • Cash: Funding Amount
Total 10,000 30,000 • POST–MONEY = PRE-MONEY+CASH
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
8. Neuronautica: The imaginary
case of a start-up with high
growth potential
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
9. The Story of Neuronautica
• Founded by three neuro-psychiatrists with collective experience of forty years in
dealing with children with Selective Learning Disabilities
• Series of products lined up around FocuScience TM, the “Science of Focussing”.
• Products claimed to bring about slow transformation in the biochemistry of the
brain without the help of chemical-based pharmaceutical products.
• Collection of exercises, games and devices to help improve retentivity and
problem solving capability through improved concentration
• Target: Children in the age group of eight to fourteen years
• Non-pharma product: Does not require clinical trials or approvals
• Sourcing / manufacturing arrangements tied up
• Distribution / marketing possibilities under consideration
– Own channel of FocuZonesTM – high investment /risk / return/ model
– Distribution through toy stores, supermarkets and malls – Moderate
investments in advertisements, inventories and marketing collaterals
– Institutional marketing through schools – Low investment, low margin, low
volume model
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
10. Product Development Market Development Exit for Early
Activity Test Marketing Mfg / Sourcing Stabilisation Biz Expansion Investors?
Proof of Concept Mkt Development Mkt Development
Biz Model Management Management
Risks
Management Sourcing / Mfg Growth
Sales & Distribution Biz Model Competition
Economics Sales & Distribution Stage 4
Economics
Stage 3
Cash 100 500 2000
18- 36 months
Stage 2
Biz Growth
Stage I 12-24 months
0-12 months
Elapsed Time
Neuronautica Development Roadmap and Funding Plan
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
11. Valuation
Two sides
& of the
same coin
Return on Investments
The centre-piece of our approach to Valuation
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
12. The Way Investor’s Money Multiplies
Investment Multiple
Exit
Entry
Valuation
Valuation
Grow at expected rate of return
Rs 10 crores Rs 80 crores
8 times ~ 50% CAGR
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
12
13. Financial data for a similar company / transaction in the market
Profit / Share = 10
RoI = 10%
Price / Share
= 100
or
Investment
Valuation of Target
Profit / Share = 10 Price / Share
or = 100
Required RoI = 10% Investment in Target
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
14. Financial data for a similar company / transaction in the market
Share Value = 1000
Share Value / Re of sales = 2
Sales = 500
Valuation of Target
Estimated Share Value = Sales x Share Value / Re of sales = 1500 x 2 = 3000
10%
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
15. Performance – Return – Valuation Nexus
• Sales
• EBIDTA Financial Return
• EBIT Performance Expectation
• PAT
• Value / Sales
Valuation • Value / Profit
Multiple • Value / EBIDTA
• Value / EBIT
Equity
Valuation
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
16. Angel Funding for Neuronautica
• The Angel’s questions
– How much money does NN require?
– How will I get my investment back with a rate of return?
Liquidity mechanism?
– How long will I have to remain invested
– What is an appropriate rate of return? How do I find a
benchmark for the rate of return in terms of similarity of
• Industry
• Stage of evolution
• Other risks – Liquidity? Capital Market risks
The answers to all of these questions impact the valuation process
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
17. Angel Investment in Neuronautica
Funds required Rs 100 lakhs
Angel’s expected exit 5 years after investment
Angel’s expected multiple on investment 8 times
Angel’s expected cash realisation on exit Rs 800 lakhs
Expected sales at the end of Year 5 Rs 320 lakhs
Valuation of NN at exit = Rs 320 lakhs x 10 Rs 3200 lakhs
% of exit valuation required = Rs 800 lakhs / Rs 3200 lakhs = 25%
To achieve his return objective the angel requires 25% equity for Rs 100 lakhs of cash
Valuation implicit in the transaction = Rs 100 lakhs / 25% = Rs 400 lakhs
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
17
18. Angel Investment in Neuronautica
Funds required Rs 100 lakhs
Angel’s expected exit 5 years after investment
Angel’s expected multiple on investment 8 times ~ 50% RoI
Angel’s expected cash realisation on exit Rs 800 lakhs
Expected sales at the end of Year 5 Rs 320 lakhs
Valuation of NN at exit = Rs 320 lakhs x 10 Rs 3200 lakhs
% of exit valuation required = Rs 800 lakhs / Rs 3200 lakhs = 25%
To achieve his return objective the angel requires 25% equity for Rs 100 lakhs of cash
Valuation implicit in the transaction = Rs 100 lakhs / 25% = Rs 400 lakhs
……..Needless this rests on many critical assumptions
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
19. Steps in Valuation
• Develop a sound business plan
• Be clear about all the underlying assumptions
• Incorporate the direct and indirect impact of the asset on the other
parts of the acquiring organisation
• Develop a set of forecast financials – P&L, Balance Sheet, Cash Flow
Statement
• Decide on appropriate method of valuation
• Estimate value
• Test Valuation under various scenarios
• Decide objective behind purchase – passive interest, joint venture,
strategic investment, controlling interest, as the case may be
• Add premium, if any, for achieving strategic or other objectives, such as
“control”.
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
20. Beyond Angel Funding for Neuronautica
• On similar lines as in the angel round the company expects to raise a
Series A and Series B round of funding as indicated below
Series A
• Amount Rs 5 crores
• % equity issued 20%
• Valuation Rs 5 crores / 0.20 = Rs 25 crores
• Series B
• Amount Rs 20 crores
• % equity issued 10%
• Valuation Rs 20 crores / 0.10 = Rs 200 crores
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
20
22. Challenges in Valuing Neuronautica
• Apart from lab level evidence hardly any information on
• The effectiveness of the product in the field
• Acceptance of the product
• Challenges in sales and distribution
• Untried management team
• How far can they take this business?
• Can you find people beyond the founders’ ability?
• Will the founders agree to step aside if found necessary?
• The economics of the business under different business / operating models
• How will the investor realise his returns?
• The virtues of staged financing
• For the entrepreneur: Helps demonstrate value
• For the investor: Helps discover value / uncover risks
• The trouble with staged financing: How will the market respond when the
company needs to raise money as planned?
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
23. Final Questions and Thoughts
1. What drives Valuation
2. How is the divergence in the outlook valuation addressed?
3. Does Valuation depend on other terms of a deal?
4. Does Valuation have to be frozen at the time of raising a
round of funding?
5. Do deals fall through on Valuation?
6. Does modelling help improve Valuation?
7. How much effort / time does one spend modelling valuation?
8. Where does one find the information required for Valuation?
9. How reliable are published information on Valuation?
10. Is it worth turning to a professional for Valuation?
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
24. Drivers of Valuation
• Environment Related
– Macro-economic outlook
– Industry Outlook
– Liquidity Overhang
• Firm Related
– Fundamentals of the firm, esp. strategic aspects.
• Deal Related
– Stage of investment and expected investment horizon
– Relative size of exposure in relation to the size of the
deal.
– Previous round investors’ expectations
– Exit prospects and path
• Valuation Trends
– Comparable deals. Caution : Compare likes.
– Public market valuations and liquidity
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
25. Rejection rate, importance and reasons by stage
*Effort measured as dollar value, as perceived by the respondents
**Rejection rate – of a total of 100 approaching the VC, the number rejected at this stage
Investment
Initial interaction &
‘Research’ and Short- Business plan Due diligence and
sharing the business
Listing presentation Negotiations
idea
Effort*
23% 52% 29% 38% 10%
Rejection
Rate**
59% 76% 17% 14% 5% 5%
• Interest mismatch - • Too small market size or • Poor planning – unrealistic • Unrealistic valuation
projections
entrepreneur is pre-qualified and coached
inappropriate vertical or potential • Too high expectations from
geography • Easily replicable plan • Entrepreneur’s rigidness the management
• Financial, marketing or to modify plans as
Key Reasons for rejection
• Closer look contrary to
Most reasons can be avoided if
• Lack of consensus on
sustainability related initial perceptions proposed by the investor
• Communication issues governance, valuation etc
• Lack of confidence in • Unable to convince about
• Lack of track record of the • Legal issues
management as opportunity feasibility/ execution/
entrepreneur bigger than what was expansion/ sustainability • Adverse report on
• Vague or unstable plan management/ business
• Bad timing – too early or proposed initially • Unrealistic demands from
• Lack of expectation entrepreneur • Management’s rigidness to
‘me-too’ offering
• Not addressing a need/ non- alignment • Lack of confidence due to accept investor’s terms
viable, too opportunistic, • Competitive aspects inability to sustain cross-
too small a market potential • Unfavourable feedback on questioning
• Execution doubts management/ market • Legal issues & other
• Non serious entrepreneurs • ‘Wildcard’ deal spoilers ‘wildcard events’
walking in just to validate
the idea
Initial stages consume over half the effort and filter-out just 76% of the deals, suggesting that there is an
opportunity to improve the efficiency of entrepreneur-investor interaction.
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
25 Source: Stern Fisher-IVCA Presentation
26. Observations on Funding and Valuation
• Multiple rounds are not just important but inevitable for early stage, high
growth businesses Control vs Wealth Trade-off
• Multiple stages mean progressive dilution
• Successful development of investee means wealth of founders’ as well as
early round investors grows in spite of decline
– Equally, unsuccessful development could mean “washing out” of
incumbents’ wealth
• Challenges
– Anticipating requirement of funds: Too much vs Too little
– Firming up key strategic choices
– Calling capital market conditions
– Bases of Valuation
– Forecasting performance and “Incentives”
Demystifying Valuation ForStartups - Dr. G. Sabarinathan
27. Information on Valuation
• Public Information easily available now
– Websites of ET, Moneycontrol…
– Commercial databases: Prowess, Capitaline,
Bloomberg
• Private Information hard to come by
• Newspaper reports
• Databases like Venture Intelligence,VC Circle
• Specialised Intermediaries
– Caveat: Be careful about special terms
29. Agenda
• What are we valuing?
• What happens when a company issues new shares to raise
new funds?
• Financing a high growth growing start-up: A flight of
imagination
• Valuation Challenges
• How do VCs and angels carry out valuation
• Steps to Valuation
• Factors Influencing Valuation
• Closing Thoughts
Demystifying Valuation 29